TEPILUKIMIG
UNII C4X2B2V5B3

Substance Identification & Data

This profile provides standardized clinical and technical data for Tepilukimig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C4X2B2V5B3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2985643-31-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
C4X2B2V5B3
CAS Registry Number
2985643-31-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TEPILUKIMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C223311
National Cancer Institute reference terminology for clinical and research data.
INN ID
13604
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tepilukimig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TEPILUKIMIG

Common Names & Synonyms

IMMUNOGLOBULIN (H-GAMMA1_L-KAPPA)_(H-GAMMA1_L-KAPPA), ANTI-(HOMO SAPIENS TSLP (THYMIC STROMAL LYMPHOPOIETIN) IL7R (INTERLEUKIN 7 RECEPTOR, IL7RA, CD127) BINDING SITE EPITOPE) AND ANTI-(HOMO SAPIENS TSLP (THYMIC STROMAL LYMPHOPOIETIN) CRLF2 (CYTOKINE RECEPTOR LIKE FACTOR 2, TSLPR, THYMIC STROMAL LYMPHOPOIETIN RECEPTOR) BINDING SITE EPITOPE), HUMANIZED MONOCLONAL ANTIBODY, BIPARATOPIC, BIVALENT
IMMUNOGLOBULIN (H-GAMMA1_L-KAPPA)_(H-GAMMA1_L-KAPPA), ANTI-(HOMO SAPIENS TSLP (THYMIC STROMAL LYMPHOPOIETIN) IL7R (INTERLEUKIN 7 RECEPTOR, IL7RA, CD127) BINDING SITE EPITOPE) AND ANTI-(HOMO SAPIENS TSLP (THYMIC STROMAL LYMPHOPOIETIN) CRLF2 (CYTOKINE RECEPTOR LIKE FACTOR 2, TSLPR, THYMIC STROMAL LYMPHOPOIETIN RECEPTOR) BINDING SITE EPITOPE), HUMANIZED MONOCLONAL ANTIBODY, BIPARATOPIC, BIVALENT (TEPILUKIMIG)
IMMUNOGLOBULIN G1 (238-PHENYLALANINE,239-GLUTAMIC ACID,335-SERINE,358-CYSTEINE,370-TRYPTOPHAN), BISPECIFIC, ANTI-(HUMAN THYMIC STROMAL LYMPHOPOIETIN) (HUMAN MONOCLONAL GR2002 .GAMMA.1-CHAIN), (230->225'),(233->228'),(358->348')-TRIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (136'-GLUTAMIC ACID,202'-ASPARTIC ACID,213'-THREONINE,233'-PHENYLALANINE,234'-GLUTAMIC ACID,267'-GLUTAMINE,273'-GLUTAMINE,330'-SERINE,348'-CYSTEINE,354'-GLUTAMINE,365'-SERINE,367'-ALANINE,406'-VALINE,418'-GLUTAMIC ACID) ANTI-(HUMAN THYMIC STROMAL LYMPHOPOIETIN) (HUMAN MONOCLONAL GR2002 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GR2002 .KAPPA.-CHAIN
TEPILUKIMIG [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus